RARA and acute promyelocytic leukemia: Further experiments showed that the introduction of the PML/RARα fusion protein to normal cells disrupted PML-NBs, whereas treatment with the pharmacological doses of retinoic acid (RA) restored PML-NBs in the APL-derived NB4 cells [11,12].